Disease Markers · 2019 · 30 citations · 27 references
MedicineCardiologyGeneticsCardiovascular GeneticsHuman GeneticsMedical GeneticsCardiovascular DiseaseCoronary Artery DiseaseDilated Cardiomyopathy GeneticsGenetic RiskGlutathione MetabolismHeart FailureAntioxidant Defense MechanismsCardiovascular Genetic RiskCoronary Artery Disease GeneticsGlutathione Redox BalanceGlutathione S-transferase ActivityGlutathione S-transferasesGlutathione SystemHeart Failure Genetics
Disturbed redox balance in heart failure (HF) might contribute to impairment of cardiac function, by oxidative damage, or by regulation of cell signaling. The role of polymorphism in glutathione transferases ( GSTs ), involved both in antioxidant defense and in regulation of apoptotic signaling pathways in HF, has been proposed. We aimed to determine whether GST genotypes exhibit differential risk effects between coronary artery disease (CAD) and idiopathic dilated cardiomyopathy (IDC) in HF patients. GSTA1 , GSTM1 , GSTP1 , and GSTT1 genotypes were determined in 194 HF patients (109 CAD, 85 IDC) and 274 age- and gender-matched controls. No significant association was found for GSTA1 , GSTM1 , and GSTT1 genotypes with HF occurrence due to either CAD or IDC. However, carriers of at least one variant GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mo>∗</mml:mo></mml:math>Val (rs1695) allele were at 1.7-fold increased HF risk than GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mo>∗</mml:mo></mml:math>Ile/Ile carriers (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.031</mml:mn></mml:math>), which was higher when combined with the variant GSTA1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mo>∗</mml:mo></mml:math>B allele (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mtext>OR</mml:mtext><mml:mo>=</mml:mo><mml:mn>2.2</mml:mn></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.034</mml:mn></mml:math>). In HF patients stratified based on the underlying cause of disease, an even stronger association was observed in HF patients due to CAD, who were carriers of a combined GSTP1 (rs1695)/ GSTA1 “risk-associated” genotype (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mtext>OR</mml:mtext><mml:mo>=</mml:mo><mml:mn>2.8</mml:mn></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.033</mml:mn></mml:math>) or a combined GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9"><mml:mo>∗</mml:mo></mml:math>Ile/Val+Val/Val (rs1695)/ GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10"><mml:mo>∗</mml:mo></mml:math>AlaVal+<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11"><mml:mo>∗</mml:mo></mml:math>ValVal (rs1138272) genotype (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M12"><mml:mtext>OR</mml:mtext><mml:mo>=</mml:mo><mml:mn>2.1</mml:mn></mml:math>, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M13"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.056</mml:mn></mml:math>). Moreover, these patients exhibited significantly decreased left ventricular end-systolic diameter compared to GSTA1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M14"><mml:mo>∗</mml:mo></mml:math>AA/ GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M15"><mml:mo>∗</mml:mo></mml:math>IleIle carriers (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M16"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.021</mml:mn></mml:math>). Higher values of ICAM-1 were found in carriers of the GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M17"><mml:mo>∗</mml:mo></mml:math>IleVal+<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M18"><mml:mo>∗</mml:mo></mml:math>ValVal (rs1695) (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M19"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.041</mml:mn></mml:math>) genotype, whereas higher TNF α was determined in carriers of the GSTP1 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M20"><mml:mo>∗</mml:mo></mml:math>AlaVal+<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M21"><mml:mo>∗</mml:mo></mml:math>ValVal genotype (rs1138272) (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M22"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.041</mml:mn></mml:math>). In conclusion, GSTP1 polymorphic variants may determine individual susceptibility to oxidative stress, inflammation, and endothelial dysfunction in HF.
27
Regulation of JNK signaling by GSTp
Victor Adler · The EMBO Journal · 1999 · 1.1K citations · Full text
Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2–ASK1 signals
Yifan Wu, Yumei Fan, Bin Xue et al. · Oncogene · 2006 · 232 citations